Global Cancer News

Cancer drug leads to ‘drastic decrease’ in HIV infection in lung cancer patient

Anne Li

The first evidence that a cancer drug may be able to eradicate HIV-infected cells in humans has now been revealed by researchers. They report that while treating an HIV-infected lung cancer patient with the cancer drug nivolumab, they observed a ‘drastic and persistent decrease’ in the reservoirs of cells in the body where the human immunodeficiency virus (HIV) is able to hide away from attack by antiretroviral therapy.

See original article at:

Post a comment